Yale Jen
Stock Analyst at Laidlaw
(0.24)
# 4,542
Out of 4,994 analysts
77
Total ratings
26.7%
Success rate
-9.1%
Average return
Main Sectors:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AEON AEON Biopharma | Initiated: Buy | $1.8 | $0.3073 | +485.75% | 1 | Sep 10, 2026 | |
| EYPT EyePoint | Reiterated: Buy | $50 → $48 | $4.34 | +1,005.99% | 4 | Aug 17, 2026 | |
| NCEL NewcelX | Initiated Coverage: Buy | $23 | $3.25 | +607.69% | 2 | Jul 13, 2026 | |
| KZIA Kazia Therapeutics | Initiated Coverage: Buy | $25 | $11.88 | +110.44% | 1 | Apr 15, 2026 | |
| FEMY Femasys | Initiated Coverage: Buy | $130 | $2.83 | +4,493.64% | 1 | Nov 20, 2025 | |
| NSRX Nasus Pharma | Initiated Coverage: Buy | $22 | $3.55 | +519.72% | 1 | Sep 29, 2025 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $110 | $32.70 | n/a | 3 | Aug 20, 2025 | |
| SNTI Senti Biosciences Holdings | Initiated Coverage: Buy | $5 | $0.299 | n/a | 1 | Jun 6, 2025 | |
| ALDX Aldeyra Therapeutics | Reiterated: Buy | $11 | $1.50 | n/a | 4 | Apr 4, 2025 | |
| NVCT Nuvectis Pharma | Initiated Coverage: Buy | $19 | $22.78 | n/a | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $7.20 | n/a | 1 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $100 | $3.18 | n/a | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 | $56.02 | n/a | 8 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $20 | $1.20 | n/a | 5 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $48 | $119.46 | n/a | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.06 | n/a | 1 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $79 | $14.74 | n/a | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 → $225 | $1.08 | n/a | 3 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $25 | $0.0001 | n/a | 5 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $1.62 | n/a | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.21 | n/a | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0071 | n/a | 2 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $2.15 | n/a | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.56 | n/a | 3 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $10 | $0.0002 | n/a | 2 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $20 | $0.4554 | n/a | 3 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.78 | $9.45 | n/a | 1 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.54 | n/a | 1 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $8.5 | $1.54 | n/a | 2 | Jul 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0007 | n/a | 2 | Aug 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $0.665 | n/a | 1 | May 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $90 | $2.49 | n/a | 2 | Nov 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.42 | n/a | 1 | Sep 27, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3.5 | $5.73 | n/a | 1 | Sep 16, 2014 |
AEON Biopharma
Sep 10, 2026
Initiated: Buy
Price Target: $1.8
Current: $0.3073
Upside: +485.75%
EyePoint
Aug 17, 2026
Reiterated: Buy
Price Target: $50 → $48
Current: $4.34
Upside: +1,005.99%
NewcelX
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $3.25
Upside: +607.69%
Kazia Therapeutics
Apr 15, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $11.88
Upside: +110.44%
Femasys
Nov 20, 2025
Initiated Coverage: Buy
Price Target: $130
Current: $2.83
Upside: +4,493.64%
Nasus Pharma
Sep 29, 2025
Initiated Coverage: Buy
Price Target: $22
Current: $3.55
Upside: +519.72%
Viking Therapeutics
Aug 20, 2025
Reiterated: Buy
Price Target: $110
Current: $32.70
Upside: n/a
Senti Biosciences Holdings
Jun 6, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $0.299
Upside: n/a
Aldeyra Therapeutics
Apr 4, 2025
Reiterated: Buy
Price Target: $11
Current: $1.50
Upside: n/a
Nuvectis Pharma
Mar 17, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $22.78
Upside: n/a
Feb 10, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $7.20
Upside: n/a
Nov 12, 2024
Reiterated: Buy
Price Target: $16 → $100
Current: $3.18
Upside: n/a
Oct 8, 2024
Reiterated: Buy
Price Target: $68
Current: $56.02
Upside: n/a
Sep 27, 2024
Reiterated: Buy
Price Target: $22 → $20
Current: $1.20
Upside: n/a
Jul 29, 2024
Initiated Coverage: Buy
Price Target: $48
Current: $119.46
Upside: n/a
Jul 23, 2024
Downgraded: Hold
Price Target: n/a
Current: $1.06
Upside: n/a
Jul 2, 2024
Reiterated: Buy
Price Target: $79
Current: $14.74
Upside: n/a
Jun 14, 2024
Reiterated: Buy
Price Target: $7.5 → $225
Current: $1.08
Upside: n/a
Jun 12, 2024
Reiterated: Buy
Price Target: $11 → $25
Current: $0.0001
Upside: n/a
May 28, 2024
Initiated Coverage: Buy
Price Target: $25
Current: $1.62
Upside: n/a
Dec 22, 2023
Downgraded: Hold
Price Target: n/a
Current: $5.21
Upside: n/a
Dec 12, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0071
Upside: n/a
Aug 28, 2023
Initiated Coverage: Buy
Price Target: $10
Current: $2.15
Upside: n/a
Aug 15, 2023
Downgraded: Hold
Price Target: n/a
Current: $1.56
Upside: n/a
Aug 7, 2023
Reiterated: Buy
Price Target: $30 → $10
Current: $0.0002
Upside: n/a
Mar 14, 2022
Reiterated: Buy
Price Target: $18 → $20
Current: $0.4554
Upside: n/a
Nov 9, 2020
Reiterated: Buy
Price Target: $5.78
Current: $9.45
Upside: n/a
Aug 24, 2020
Downgraded: Hold
Price Target: n/a
Current: $0.54
Upside: n/a
Jul 31, 2020
Reiterated: Buy
Price Target: $6 → $8.5
Current: $1.54
Upside: n/a
Aug 9, 2019
Downgraded: Hold
Price Target: n/a
Current: $0.0007
Upside: n/a
May 20, 2019
Initiated Coverage: Buy
Price Target: $10
Current: $0.665
Upside: n/a
Nov 15, 2018
Reiterated: Buy
Price Target: $4 → $90
Current: $2.49
Upside: n/a
Sep 27, 2016
Reiterated: Hold
Price Target: n/a
Current: $5.42
Upside: n/a
Sep 16, 2014
Initiated Coverage: Buy
Price Target: $3.5
Current: $5.73
Upside: n/a